SwiftPharma and Benno Therapeutics are taking a next step in their collaboration by establishing a dedicated R&D presence in Leuven. While SwiftPharma remains headquartered at Thor Park in Genk, the company is expanding its research footprint through a new site at the Leuven Lab Hotel.
This is not a traditional office, but a shared, collaborative environment where teams from both organizations will work side by side in the same lab setting. By integrating their infrastructure, the partners aim to reduce physical distance between research activities and foster closer day-to-day collaboration.
The site will support joint projects, with a focus on oncology and beyond.
About SwiftPharma
SwiftPharma is a Belgium-based biopharmaceutical company focused on the discovery and development of innovative therapies. The company specializes in molecular farming technologies, enabling the production of complex biological molecules. With its headquarters at Thor Park in Genk, SwiftPharma is committed to advancing next-generation treatments through cutting-edge research and strategic partnerships.
About Benno Therapeutics
Benno Therapeutics is a biotechnology company dedicated to developing novel therapeutic solutions, with a strong emphasis on oncology. The company focuses on translating scientific innovation into impactful treatments, working through collaborations to accelerate the development of its pipeline and improve patient outcomes.
Read the full LinkedIn article here.
